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There is increasing interest in the identification of factors associated with liver disease
progression in patients infected with hepatitis C virus (HCV). We assessed host-related factors
associated with a histologically advanced stage of this disease and determined the rate of liver
fibrosis progression in HCV-infected patients. We included patients submitted to liver biopsy,
who were anti-HCV and HCV RNA positive, who showed a parenteral risk factor (blood transfusion
or intravenous drug use), and who gave information about alcohol consumption.Patients were
divided into two groups for analysis: group 1 - grades 0 to 2; group 2 - grades 3 to 4. The groups
were compared in terms of sex, age at the time of infection, estimated duration of infection and
alcoholism. The rate of fibrosis progression (index of fibrosis) was determined based on the
relationship between disease stage and duration of infection (years). Logistic regression analysis
revealed that age at the time of infection (P<0.01; 95% CI 1.06-1.22) and the duration of infection
(P<0.01; 95% CI 1.06-1.32) were independently associated with a more advanced stage of hepatitis
C. The median index of fibrosis was 0.14 for the group as a whole. A significant difference in the
index of fibrosis was observed between patients aged < 40 years at infection (median = 0.11) and
patients aged ≥ 40 years (median = 0.47). The main factors associated with  a more rapid fibrosis
progression were age at the time of infection and the estimated duration of infection. Patients who
acquired HCV after 40 years of age showed a higher rate of fibrosis progression.
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Hepatitis C virus (HCV) infection affects people
worldwide and about 170 million individuals are
estimated to be chronically infected with HCV. Several
aspects of the natural history of this disease are still not
completely understood.
After acute infection, viremia persists in 85% of the
patients [1] and most of them develop chronic hepatitis.
Different studies have shown variable rates of
progression to cirrhosis in patients with chronic hepatitis
C according to the group analyzed. Only 2% of women
contaminated through the use of immunoglobulin
evolved to cirrhosis over a follow-up period of 17
years [2], while cirrhosis was observed in 51% of
patients contaminated through blood transfusion [3].
During cirrhosis, patients may develop complications
secondary to portal hypertension and/or hepatic
insufficiency; they may also have a higher risk for
hepatocellular carcinoma (2 to 4% per year) [4, 5].
These complications are intimately related to the degree
of fibrosis and destructuring of the lobular architecture
and, therefore, staging represents the main prognostic
marker in patients with chronic hepatitis C.
Knowledge about the factors that influence the
natural history of hepatitis C is important for the clinical
treatment of patients and for the implementation of
preventive and therapeutic measures.
Our objective was to assess the effect of host-
related factors on the histological manifestations of
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chronic hepatitis C and to determine the rate of liver
fibrosis progression in patients chronically infected with
HCV.
Material and Methods
Data were obtained from the medical records of
patients seen at the Hepatitis Outpatient Clinic of São
Paulo Hospital, Escola Paulista de Medicina, from
1994 to 2000.
HCV-infected patients who met the following criteria
were included in the study: patients who tested positive
for HCV RNA, who showed a parenteral risk factor
(blood transfusion and/or intravenous drug use), who
reported information about alcohol consumption, and
for whom a liver biopsy adequate for analysis was
available.
Only patients who could provide information about
the date of blood transfusion and/or intravenous drug
use were included. The duration of infection was
estimated based on the date of the first blood transfusion
or the first year of intravenous drug use, with either
occurrence being considered the probable date of
infection.
Alcohol consumption was determined as grams of
ethanol per day, and only patients for whom sufficient
data for the calculation of daily ethanol consumption
were available were included.
A liver biopsy was considered to be adequate for
analysis when it provided a representative fragment for
histological evaluation. Staging was based on the grade
of fibrosis and destructuring of the lobular architecture,
and stages were classified according to the
semiquantitative criteria proposed by Ludwig and
Desmet [6, 7] for the classification of chronic hepatitis:
0 - absence of fibrosis, 1 - portal fibrosis, 2 - portal-
portal septa with preserved lobular architecture, 3 -
portal-portal and portal-central septa, with the presence
of nodules, but preserved areas of lobular architecture,
and 4 - cirrhosis.
Patients co-infected with hepatitis B virus and/or
HIV, patients with chronic renal failure,
immunosuppressed patients, and patients with a history
of previous treatment were excluded from the study.
For analysis of factors associated with a more
advanced stage of the disease, patients were divided
into two groups: group 1 consisted of patients in stage
0, 1 or 2 of the disease, and group 2 consisted of
patients in stage 3 or 4. Groups were compared
regarding sex, age at the time of infection, estimated
duration of infection and alcoholism. Patients were
considered to be alcoholics when they reported an
ethanol consumption higher than 50g per day.
The index of fibrosis was determined by dividing
disease stage (0 to 4) by duration of infection (years)
in order to estimate the mean time of progression to
cirrhosis among patients chronically infected with HCV.
The chi-square test, Student t-test and Mann-
Whitney test were used for statistical analysis. Variables
that provided a P value <0.20 upon bivariate analysis
were submitted to logistic regression analysis for the
identification of variables independently associated with
a more advanced stage.
Results
A total of 153 patients with a history of blood
transfusion or intravenous drug use were initially
evaluated, and 94 patients who did not meet the criteria
described above were excluded. Exclusion criteria were
the lack of information about the probable date of
infection in 40 patients, insufficient information for the
quantification of alcohol consumption in 37, and an
inadequate liver biopsy fragment in 17.
Fifty-nine patients (Table 1), 43 (73%) men and 16
(27%) women, were included in the study. The mean
age at the time of infection was 29 ± 14 years.Forty-
three (73%) patients had a history of blood transfusion
and 16 (27%) had a history of intravenous drug use.
The mean duration of infection was 14 ± 7
years.Twenty-two (37%) patients reported an ethanol
consumption higher than 50 g/day and were classified
as alcoholics.
The distribution of the patients according to the stage
of chronic hepatitis is shown in Figure 1. Thirty-six
(61%) patients were in stages 0 to 2 and were included
in group 1; group 2 consisted of 23 (39%) patients in
stage 3 or 4.
Factors Associated with Fibrosis in Hepatitis C
BJID 2002; 6 (October) 221
www.infecto.org.br/bjid.htm
Factors Associated with Fibrosis in Hepatitis C
No significant difference in gender (75% males in
group 1 and 70% in group 2; P=0.65) or alcoholism
(39% alcoholics in group 1 and 35% in group 2;
P=0.75) was observed between groups (Table 2).
Mean duration of infection was 13 ± 7 years for group
1 and 15 ± 8 years for group 2 (P=0.20). Mean age at
the time of infection was 24 ± 11 years for group 1 and
37 ± 15 years for group 2 (P=0.001).
Logistic regression analysis demonstrated that age
at the time of infection (P<0.01, 95% CI 1.06-1.22)
and duration of infection (P<0.01, 95% CI 1.06-1.32)
were independently associated with a more advanced
stage of the disease (Table 3).
The median index of fibrosis was 0.14 for the group
as a whole.
Since age at the time of infection was identified
as a factor independently associated with a more
advanced stage, the index of fibrosis was
determined according to age at infection (< 40
and ≥ 40 years). The median index of fibrosis
among patients aged < 40 years at infection was
0.11, while this index was 0.47 among patients
Table 1. Characteristics of the patients (n=59)
P OR 95% CI
Age at infection < 0.001 1.14 1.06-1.22
Duration of infection 0.003 1.18 1.06-1.32
Table 3. Logistic regression analysis (final model)
Group 1 Group 2 P
(n=39) (n=23)
Male 75% 70% 0.65
Mean age at infection (years) 24 ± 11 37 ± 15 0.001
Mean duration of infection (years) 13 ± 7 15 ± 8 0.20
Alcoholism 39% 35% 0.75
Table 2. Comparison between groups
Characteristic Results
Male 43 (73%)
Mean duration of infection (years) 14±7
Mean age at the time of infection (years) 29±14
History of blood transfusion 43 (73%)
History of intravenous drug use 16 (27%)
Alcoholism (ethanol > 50 g/day) 22 (37%)
Grade 3-4 hepatitis C 23 (39%)
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Figure 2. Mean time of progression to cirrhosis according to age at the time of infection
Figure 1. Patient distribution of patients according to disease stage
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who contracted the infection after 40 years; this
difference was found to be significant (P<0.001).
Discussion
The only host-related factors showing an
independent correlation with the stage of chronic
hepatitis were age at the time of infection and duration
of infection.
No significant difference in gender or alcoholism was
observed between groups 1 and 2. A correlation
between a higher grade of fibrosis and the male sex
has been reported in studies on the natural history of
liver fibrosis [8, 9], but no explanation for this potential
association has been provided thus far. It is possible
that in these studies such a correlation has been
established based on an uncontrolled variable.
Alcohol consumption is a factor that contributes to
the progression of liver fibrosis in patients with chronic
hepatitis C; however, we found no correlation between
alcoholism and a more advanced stage of the disease.
Alcohol consumption is a factor difficult to evaluate,
and it is possible that, in many cases, true daily ethanol
consumption was not reported correctly by the patients,
thus underestimating alcohol intake, especially among
patients with high consumption. Another explanation is
the fact that patients in a more advanced stage of the
disease had received recommendations to abstain from
alcohol before starting follow-up at our outpatient clinic.
The duration of infection, when submitted to logistic
regression analysis for the control of the remaining
variables, was identified as a variable independently
associated with a more advanced stage of the disease.
This correlation was predictable since fibrosis develops
progressively over time and, therefore, a higher degree
of fibrosis was expected for patients with a longer
duration of infection.
Considering the importance of the duration of
infection for the progression of chronic hepatitis C, the
index of fibrosis was determined based on the
relationship between disease stage and the duration of
infection (in years). The median index of fibrosis was
0.14 for the group as a whole. Based on this value, the
mean progression for chronic HCV-infected patients
with grade 4 disease (cirrhosis) was estimated to be
approximately 28.5 years. This result is similar to the
30 years mean time of progression to cirrhosis of
estimated by Poynard [8].
Bivariate analysis showed a significant correlation
between age at the time of infection and a more
advanced stage of the disease (P=0.001), with this
independent association also being observed upon
logistic regression analysis. Age at the time of infection
was found to be one of the most important host-related
factors in the progression of liver fibrosis, as also
observed in other studies [8-10].
In order to assess the impact of this variable on the
natural history of HCV infection, the liver fibrosis index
was determined according to age group, using a limit
of 40 years as a categorization criterion. Patients who
were infected after 40 years of age had a higher rate of
fibrosis progression (0.47 vs 0.11; P<0.001).
The mean time of progression to cirrhosis was
estimated for each age group based on the median index
of fibrosis, with patients infected at less than 40 years
of age taking, on average, 36.4 years to develop
cirrhosis, while patients infected after 40 years
presented a more rapid evolution, with the cirrhosis
stage being reached within about 8.5 years (Figure 2).
These findings explain why different studies on the
natural history of hepatitis C have shown discrepant
results regarding the rate of progression to cirrhosis.
In a study carried out in Ireland on a cohort of young
women contaminated through the use of
immunoglobulin, only 2% of the women evolved to
cirrhosis within a 17 year follow-up period [2]. Similar
findings were reported for 152 women infected through
immunoglobulin in Germany [11]. In our study, no
patient developed cirrhosis after 15 years of infection.
Similarly, Seeff et al. [12] observed liver disease in only
11.8% of HCV-infected patients after 45 years of
infection. In this study, analysis of the causes of mortality
after this long period of time revealed that death was
attributable to hepatitis C in only 5.9% of cases.
Studies conducted on children and adolescents have
demonstrated a clinically benign course of HCV
infection in this age group [13-15]. These studies
reinforce the influence of age on the natural history of
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hepatitis C. On the other hand, studies conducted on
older patients contaminated through blood transfusion
have reported cirrhosis in about 50% of cases [3, 16, 17].
In summary, we conclude that the main factors
associated with an advanced stage of chronic hepatitis
C are age at the time of infection and the estimated
duration of infection. Patients who acquired HCV after
40 years of age had a higher rate of fibrosis progression,
and reached the stage of liver cirrhosis within a period
of time which was 4 to 5 times shorter than that
observed for patients who were infected at a younger
age. These data are important for the clinical follow-
up of patients with hepatitis C and each patient should
be submitted to individualized analysis when
establishing a disease prognosis, since host-related
variables, such as those analyzed here, have a strong
impact on the natural history of HCV infection.
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